官方服务：
资源简介：
Drug resistance in leprosy
应用场景：
创建时间：
2024-05-31
相关数据集
Comparison of the results of three molecular assays of drug resistance using clinical samples of leprosy patients.
Comparison of the results of three molecular assays of drug resistance using clinical samples of leprosy patients.
NIAID Data Ecosystem80
Concordance of results for the DNA strip test (GenoType LepraeDR) and the susceptibility phenotypic and genotypic pattern of antibiotic resistance for the M. leprae strains studied.
*For strains growing in vivo and yielding interpretable susceptibility results. Tests were stopped for dapsone due to new regulation for antibiotic animal feeding. Tests for ofloxacin were restricted
Figshare2015-12-02 更新30
IC 50 s of FQs against DNA gyrases of WT and mutant M . leprae .
IC50s of FQs against DNA gyrases of WT and mutant M. leprae.
NIAID Data Ecosystem30
Mycobacterium leprae rifampicin strains resistance investigation in one patient
A case of M. leprae rifampicin resistance (rpoB, S456L) after irregular anti-leprosy treatments since 1971 is reported. Whole-genome sequencing from four samples revealed a low genetic variation among
NIAID Data Ecosystem60
qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients
Background Real-Time PCR-High Resolution Melting (qPCR-HRM) analysis has been recently described for rapid drug susceptibility testing (DST) of Mycobacterium leprae. The purpose of the current study w
NIAID Data Ecosystem30
